We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs.
- Authors
D’AMATO, S.; NUNNARI, G.; TRIMARCHI, G.; SQUERI, A.; CANCELLIERI, A.; SQUERI, R.; PELLICANÒ, G. F.
- Abstract
OBJECTIVE: On March 11, 2020, the World Health Organization (WHO) has declared the novel coronavirus (COVID-19) outbreak as a global pandemic. COVID-19 pandemic has impacted health services, including immunization programs, with a consequent reduction in vaccination coverage in those categories for which the prevention of vaccine-preventable diseases is strongly recommended. SUBJECTS AND METHODS: We conducted a retrospective cross-sectional study on the general population and on PLWHs, comparing anti-human papillomavirus (HPV) vaccination coverage data in 2019, before COVID-19 pandemic, and the 2020 data, after the announcement of the pandemic state and the lockdown and the implementation of restrictive measures to contain the contagion. RESULTS: Compared to 2019, 2020 data show a 42% reduction in HPV vaccine coverage in the general population and 36% in PLWHs. The greatest reduction in anti-HPV vaccination coverage occurred during periods of greatest restriction and mainly concerned the general population. CONCLUSIONS: The prevention of vaccine-preventable diseases remains essential. Above all, it is essential to increase and recover the anti-HPV vaccine coverage, in consideration of the data that show its preventive oncological efficacy.
- Subjects
WORLD Health Organization; VACCINATION coverage; COVID-19 pandemic; SARS-CoV-2; PAPILLOMAVIRUSES; HUMAN papillomavirus vaccines; PREVENTIVE medicine; MEDICAL care
- Publication
European Review for Medical & Pharmacological Sciences, 2022, Vol 26, Issue 19, p7285
- ISSN
1128-3602
- Publication type
Article